Gepotidacin is an oral, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by blocking 2 different type II topoisomerase enzymes.
The FDA has approved GSK’s gepotidacin (Blujepa) for treating uncomplicated urinary tract infections (uUTIs) in females aged ...
The approval of gepotidacin (Blujepa; GSK) introduces the first new class of oral antibiotics for uncomplicated urinary tract ...
Blujepa marks the first new oral antibiotic to gain FDA approval for uncomplicated urinary tract infections in nearly 30 ...
Discover the commercial and brand names of the generic drug Nitrofurantoin. This indispensable guide is essential for healthcare professionals, patients, caregivers, and anyone seeking to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback